top of page


Journey of 2Sevnty Bio - Spin-off, Key Onco-deals, and Acquisition
🤝 Bristol Myers Squibb is set to acquire 2seventy bio in an all-cash transaction valued at approximately $286 million. After...
Oncofocus Team
Jun 201 min read
1 view


CGT Watch Newsletter: March'25 Edition
Dear Readers, Welcome to our inaugural CGT Watch newsletter! We’re excited to bring you monthly highlights on novel targets, innovative...
Oncofocus Team
Mar 206 min read
9 views


Understanding Multiple Myeloma: An Infographic Overview
Since March is Multiple Myeloma Awareness Month, we at Oncofocus have created an informative infographic highlighting the current...
Oncofocus Team
Mar 29, 20231 min read
79 views
bottom of page